Fact-checked by Grok 2 weeks ago

Cholagogue

A cholagogue is a medicinal agent that stimulates the contraction of the gallbladder to promote the flow of bile into the duodenum.^[1] Cholagogues differ from choleretics, which primarily increase bile production by the liver, by focusing on the release of pre-formed bile stored in the gallbladder to facilitate digestion of fats and excretion of waste products.^[2]^[1] They are employed in the management of hepatobiliary disorders, including gallstones, jaundice, and cholestasis, where impaired bile flow contributes to symptoms like abdominal pain, nausea, and elevated bilirubin levels.^[1] Pharmaceutical cholagogues include ursodeoxycholic acid, which is approved for treating primary biliary cholangitis by improving bile flow and reducing liver damage.^[2] Herbal examples encompass globe artichoke (Cynara scolymus), which enhances bile secretion and provides hepatoprotective effects.^[1] These agents are contraindicated in cases of acute biliary obstruction or severe liver failure due to the risk of exacerbating complications.^[1]

Definition and Mechanism

Definition

A cholagogue is a medicinal agent that promotes the discharge of bile from the gallbladder into the duodenum. The term derives from the Greek words "chole," meaning bile, and "agein," meaning to lead or draw forth, reflecting its role in facilitating bile expulsion.^[3]^[4] In its primary function, a cholagogue stimulates contraction of the gallbladder, thereby increasing the flow of stored bile through the common bile duct into the small intestine to aid digestion. This action enhances the delivery of bile for emulsifying dietary fats, breaking them into smaller droplets to enable enzymatic breakdown by lipases.^[1]^[5] Within the framework of humoral medicine, cholagogues were traditionally regarded as substances that purge excess bile downward through the digestive tract, thereby restoring balance among the body's humors—particularly yellow bile, associated with the choleric temperament.^[6] Bile itself, produced continuously by the liver at a rate of approximately 600 to 1,000 milliliters per day and concentrated in the gallbladder, serves as a critical emulsifier in fat digestion, with its amphipathic bile acids dispersing lipid globules to increase their surface area for absorption in the duodenum.^[5]^[7]

Mechanism of Action

Cholagogues exert their primary effect by stimulating the contraction of the gallbladder, thereby facilitating the expulsion of stored bile into the duodenum for digestive purposes. This process involves the excitation of smooth muscle cells in the gallbladder wall, which is typically mediated through the release of cholecystokinin (CCK), a hormone secreted by enteroendocrine cells in the duodenum in response to the presence of fats or proteins in the chyme. CCK binds to CCK-A receptors on gallbladder smooth muscle, triggering calcium-dependent contraction and coordinated relaxation of the sphincter of Oddi to allow bile passage.^[8]^[1] This coordinated motility ensures efficient emptying of the biliary system without altering the rate of bile synthesis in hepatocytes. The biochemical pathways involved often include modulation of ion channels and second messengers, such as increased intracellular calcium, but the net effect remains focused on mobilizing existing bile reserves rather than augmenting production.^[9]^[10] The action of cholagogues is closely integrated with normal digestive signaling, particularly the enterohepatic circulation triggered by meals rich in lipids. Bitter compounds or fatty acids in the diet stimulate CCK secretion, mimicking or amplifying the physiological reflex that prepares the biliary tract for emulsification of dietary fats. This mechanism supports lipid digestion and absorption while preventing bile stasis, though cholagogues do not independently increase overall bile volume, distinguishing their role from that of agents that stimulate hepatic secretion.^[8]^[1]

Historical Development

Origins in Traditional Medicine

The concept of cholagogues traces its roots to ancient Greek and Roman medicine, where the humoral theory posited that health depended on the balance of four bodily fluids, including yellow bile or choler, produced by the liver. Hippocrates and his followers viewed excess choler as causing conditions like jaundice and irritability, recommending purgative remedies to discharge it downward through the intestines to restore equilibrium. Galen further elaborated this framework in the 2nd century CE, emphasizing herbal and dietary interventions to stimulate bile flow and eliminate imbalances, influencing medical practice for centuries.^[11] In traditional systems worldwide, similar principles emerged to address bile-related disorders. Ayurveda employed bitter herbs such as guduchi (Tinospora cordifolia) to balance pitta dosha, the fiery energy associated with digestion and liver function, thereby promoting bile secretion and alleviating heat-induced stagnation. In Traditional Chinese Medicine, herbs like chai hu (Bupleurum chinense) were used to soothe liver qi stagnation, which was believed to obstruct bile flow and contribute to symptoms like abdominal distension and jaundice, facilitating smoother hepatic and gallbladder activity. European folk medicine drew on humoral ideas, utilizing plants to treat jaundice and liver complaints through bile promotion. Early herbal applications in medieval Europe highlighted plants like dandelion (Taraxacum officinale), referenced in herbals for stimulating bile production to relieve jaundice, based on the doctrine of signatures where its yellow flowers mimicked the condition's hue. These uses lacked empirical validation but reflected widespread reliance on cholagogue-like effects for hepatic support. By the 19th century, cholagogues appeared in patent medicines, such as Osgood's India Cholagogue, introduced in 1830 by Dr. Charles Osgood in the United States as a remedy for bilious illnesses, fevers, and liver purging, often marketed with pamphlets claiming efficacy against ague and digestive woes.^[12]

Evolution in Modern Pharmacology

The early 20th century marked a pivotal shift in the understanding of cholagogues through the biochemical isolation and characterization of key bile components. Bile salts, long recognized for their detergent-like properties, were extensively studied in the 1920s for their role in facilitating bile flow and emulsification, with dehydrocholic acid— a oxidized derivative—demonstrated as an effective cholagogue in human trials by 1924.^[13] Simultaneously, cholecystokinin (CCK) was identified in 1928 from jejunal extracts by Ivy and Oldberg as the primary hormone responsible for gallbladder contraction and bile evacuation, establishing a foundational mechanism for cholagogue action.^[14] These discoveries spurred the synthesis of CCK analogs starting in the mid-20th century, such as modified tetrapeptides that mimicked gallbladder stimulation while enhancing stability for potential therapeutic use.^[15] Post-World War II advancements in pharmacology introduced targeted synthetic cholagogues, building on wartime gains in organic synthesis and clinical testing protocols. Florantyrone, developed in the 1950s, represented a key milestone as a non-steroidal agent specifically for biliary dyskinesia, promoting coordinated gallbladder emptying and bile duct relaxation. Clinical trials in the late 1950s confirmed its efficacy, showing increased hepatic bile secretion rates and modifications to bile's chemical composition, such as elevated cholesterol solubility, without significant adverse effects in short-term use.^[16] This era's emphasis on evidence-based validation through randomized studies distinguished modern cholagogues from earlier empirical approaches, paving the way for their integration into gastroenterological practice. From the 1970s to the 2000s, renewed interest in herbal agents revitalized cholagogue research, particularly in hepatology, amid growing recognition of silymarin from milk thistle (Silybum marianum) as a potent natural promoter of bile dynamics. Endorsed by the World Health Organization in the 1970s as a standardized hepatoprotective extract, silymarin underwent extensive preclinical and clinical scrutiny, revealing its capacity to boost bile acid-dependent choleresis by enhancing hepatic synthesis and biliary excretion of bile salts.^[17] Key studies, including rat models from the 1990s, demonstrated up to 30% increases in bile flow without altering bile acid-independent fractions, attributing effects to silymarin's modulation of transporter proteins like BSEP.^[18] This body of work, spanning over three decades, solidified silymarin's role in supportive therapy for cholestatic disorders, bridging traditional uses with pharmacological rigor.^[19] As of 2025, cholagogues have evolved into core components of functional medicine and nutraceutical strategies, emphasizing holistic support for bile homeostasis in digestive health. Synthetic and herbal variants, including silymarin-based formulations, are increasingly formulated as adjuncts in protocols for conditions like non-alcoholic fatty liver disease and irritable bowel syndrome, reflecting a shift toward personalized, integrative applications.^[9]

Types and Examples

Herbal Cholagogues

Herbal cholagogues are plant-derived substances that promote bile flow from the gallbladder, often through stimulation of hepatic secretion or gallbladder contraction, distinguishing them from purely choleretic agents that primarily increase bile production in the liver. These herbs have been employed in traditional practices for supporting digestive health, particularly in conditions involving sluggish bile flow, and modern research has begun to elucidate their mechanisms via active compounds like sesquiterpenes, flavonoids, and polyphenols. While standardization varies, clinical and preclinical studies indicate their potential to enhance biliary function without the uniformity of pharmaceutical counterparts. Among the most studied herbal cholagogues is dandelion root (Taraxacum officinale), which contains sesquiterpene lactones such as germacranolides that stimulate gallbladder contraction and increase bile secretion. Preclinical evidence from rat models shows that dandelion leaf extracts can elevate bile output by up to 40%, while studies in dogs using root decoctions have demonstrated a doubling of bile production, supporting its role in promoting biliary motility. Artichoke leaf (Cynara scolymus) acts via cynarin, a caffeoylquinic acid derivative, which indirectly enhances bile secretion by increasing the size and number of hepatic bile ducts. Clinical trials, including a double-blind, placebo-controlled study, have reported significant increases in bile flow—up to 127% within 30 minutes and 151% after 60 minutes—following artichoke leaf extract administration in healthy subjects. Other notable herbal cholagogues include milk thistle (Silybum marianum), whose silymarin complex provides liver support and facilitates bile flow through antioxidant and membrane-stabilizing effects on hepatocytes. Animal and human studies indicate silymarin enhances bile excretion, contributing to improved biliary dynamics in liver-compromised states. Turmeric (Curcuma longa) contains curcumin, which aids biliary motility by acting as a cholagogue, with a single 20 mg dose increasing bile flow by 29% in healthy volunteers as measured by scintigraphy. Barberry (Berberis vulgaris) features berberine, an isoquinoline alkaloid that promotes digestive purging and bile discharge, with evidence from animal models showing increased fecal bile acid loss and traditional use as a cholagogue for supporting gallbladder function. These herbs are commonly prepared as teas, tinctures, or standardized supplements to leverage their bile-promoting effects, with clinical studies in healthy subjects demonstrating modest increases in bile output—typically 20-30%—following oral administration of extracts. For instance, turmeric and artichoke formulations have shown this range in controlled trials, underscoring their utility in enhancing postprandial bile release without adverse effects at recommended doses. In cultural contexts, Western herbalism frequently incorporates dandelion, artichoke, and milk thistle for gallbladder support, drawing from European traditions of using bitters to stimulate digestion. Ayurvedic medicine highlights bhumi amla (Phyllanthus niruri), a hepatoprotective herb valued for detoxifying the liver and implicitly aiding bile flow through its cooling and purgative properties on the biliary system.

Pharmaceutical Cholagogues

Pharmaceutical cholagogues encompass synthetic or isolated compounds designed to stimulate gallbladder contraction and bile flow, distinguishing them from herbal variants through standardized formulations and precise pharmacokinetics. These agents are primarily employed in conditions involving impaired biliary motility or cholesterol-based gallstones, with development rooted in mid-20th-century efforts to mimic endogenous bile acid regulation for targeted hepatobiliary therapy.^[20] A prominent synthetic example is florantyrone, a fluoranthene derivative developed in the 1950s for treating biliary dyskinesia, a motility disorder characterized by dysfunctional gallbladder emptying. Florantyrone promotes bile secretion and flow, acting as a mild hydrocholeretic by proportionally increasing outputs of bile and bile acids without altering their chemical or physical properties significantly, as demonstrated in early hepatic bile studies. Its pharmacological profile includes small-molecule absorption, though specific bioavailability data remain limited due to its withdrawn status in many markets.^[21]^[16] Ursodeoxycholic acid (UDCA), a naturally occurring yet pharmaceutically isolated bile acid, serves as a key agent with both choleretic and cholagogue properties, particularly in gallstone dissolution. UDCA reduces hepatic cholesterol secretion and saturation in bile, facilitating the breakdown of radiolucent, noncalcified cholesterol gallstones while enhancing bile flow through upregulation of hepatobiliary transport proteins like AE2. Approved by the FDA in 1987 for short-term gallstone dissolution prior to elective cholecystectomy, UDCA is dosed at 13-15 mg/kg/day orally, with incomplete bioavailability due to passive diffusion absorption and approximately 50% first-pass hepatic extraction. Randomized controlled trials (RCTs) have shown gallstone dissolution in up to 60% of patients after treatment, with reduced dyspepsia symptoms, though efficacy depends on stone size and patient compliance. UDCA also exhibits cholagogue effects by modulating bile acid pools and protecting cholangiocytes, contributing to improved biliary patency in dissolution contexts.^[22]^[23]^[24] Chenodeoxycholic acid (CDCA, marketed as chenodiol) represents another isolated bile acid with established cholagogue action, primarily for dissolving cholesterol gallstones by inhibiting hepatic cholesterol synthesis and lowering bile lithogenicity. CDCA increases bile flow and reduces cholesterol secretion at low doses, with RCTs demonstrating dissolution rates of 15-30% after 2 years of therapy, particularly effective for small stones at higher doses compared to UDCA in direct comparisons. FDA-approved for gallstone dissolution, CDCA's bioavailability involves efficient small-intestinal absorption, though long-term use requires monitoring due to potential hepatotoxicity. Its pharmacological profile supports use in specific indications like post-cholecystectomy syndrome management, where bile flow enhancement aids symptom relief.^[25]^[26]^[27] Magnesium sulfate, administered orally as a pharmaceutical preparation, functions as an acute cholagogue by reflexively relaxing the sphincter of Oddi and stimulating gallbladder contraction via cholecystokinin (CCK) release, aiding biliary stimulation in diagnostic or therapeutic settings. While intravenous forms are explored for general biliary support, oral dosing (typically 15-30 g in solution) is standard for cholagogue effects, with peak gallbladder emptying observed within 30 minutes in ultrasound-monitored studies. Regulatory approval focuses on its osmotic laxative role, but its cholagogue utility is evidenced in protocols for biliary patency assessment without formal FDA endorsement for this indication alone. RCTs on magnesium sulfate's biliary effects are sparse but confirm enhanced CCK-mediated emptying, supporting its adjunctive use in motility disorders.^[28]^[29]^[30] Overall, these pharmaceutical cholagogues underwent regulatory scrutiny for targeted biliary indications, with UDCA and CDCA holding FDA approvals for gallstone-related uses, including supportive roles in post-cholecystectomy syndrome through bile flow optimization. Evidence from RCTs underscores their efficacy in improving bile duct patency and dissolution rates, with bioavailability profiles guiding clinical dosing to balance therapeutic benefits and hepatic load.^[23]^[26]

Clinical Applications

Therapeutic Uses

Cholagogues are primarily indicated for the management of biliary dyskinesia, a motility disorder characterized by impaired gallbladder emptying, where they promote bile discharge to relieve symptoms such as epigastric pain and bloating.^[1] They are also employed for constipation arising from inadequate bile flow, which impairs fat emulsification and subsequent bowel lubrication, as well as for dyspepsia involving hepatic or biliary components.^[1] Additionally, cholagogues provide supportive therapy in non-obstructive jaundice by facilitating bilirubin excretion through enhanced bile flow.^[1] In adjunctive roles, cholagogues enhance fat digestion in malabsorption syndromes, such as those secondary to pancreatic insufficiency, by increasing bile availability for lipid emulsification and absorption.^[10] Herbal cholagogues, including extracts from globe artichoke (Cynara scolymus), further support liver function in chronic hepatitis by promoting biliary drainage and reducing hepatic load.^[1] Administration protocols typically involve pre-meal dosing, such as 320-640 mg of standardized artichoke leaf extract taken 30 minutes before meals, to synchronize bile release with food intake and optimize digestive support.^[31] Cholagogues are often combined with choleretics, like ursodeoxycholic acid, for comprehensive biliary therapy that addresses both bile secretion and expulsion.^[10] Clinical evidence from randomized controlled trials supports these applications; for instance, a six-week placebo-controlled study of 244 patients with functional dyspepsia demonstrated significant symptom alleviation with artichoke leaf extract (p < 0.001), including reduced nausea and abdominal discomfort.^[32] An open-label study reported an average 40% reduction in global dyspepsia scores after two months of artichoke leaf extract therapy.^[31] These findings indicate moderate efficacy in improving gallbladder-related motility and digestive symptoms, though larger meta-analyses are needed for broader biliary disorders.^[33]

Contraindications and Safety

Cholagogues are absolutely contraindicated in cases of acute liver failure, as they may exacerbate hepatic stress and impair recovery.^[34] They are also contraindicated in obstructive jaundice and painful gallstones, where increased bile flow could provoke biliary colic or gallbladder rupture due to heightened contractile activity on obstructed ducts.^[35]^[36] Cholecystitis similarly warrants avoidance, as cholagogues can intensify inflammation in the gallbladder.^[34] Relative contraindications include pregnancy, particularly for herbal cholagogues such as barberry (Berberis vulgaris), which may stimulate uterine contractions and increase the risk of miscarriage or neonatal kernicterus due to berberine content.^[37]^[38] Individuals with a history of biliary obstruction require caution, as residual issues could lead to recurrent complications.^[36] Additionally, certain herbal cholagogues like turmeric (Curcuma longa) interact with anticoagulants such as warfarin, potentially prolonging bleeding times through inhibition of platelet aggregation and enhancement of anticoagulant effects.^[39]^[40] Common side effects of cholagogues include gastrointestinal upset, such as abdominal pain and diarrhea, resulting from excessive bile secretion into the intestines.^[36] Rare adverse reactions encompass allergic responses to herbal components, though overall effects are typically mild and infrequent.^[1] Prolonged use of synthetic cholagogues may heighten these risks, necessitating limited duration.^[36] Prior to initiating cholagogue therapy, liver function tests are recommended to assess baseline hepatic status and rule out contraindications.^[34] The World Health Organization's guidelines on herbal medicine safety emphasize pharmacovigilance and caution against unsupervised use, particularly for hepatobiliary agents.^[41] As of 2025, the European Medicines Agency advises dose restrictions for alkaloid-containing herbals (e.g., not exceeding 2.5 mg daily for greater celandine) to mitigate hepatotoxicity risks.^[42]

Choleretics

Choleretics are substances that stimulate hepatocytes to produce more bile, thereby increasing its overall volume and modifying its composition, such as elevating bicarbonate content for a less acidic profile.^[43] This process enhances the liver's secretory capacity without primarily addressing bile flow obstruction.^[7] The mechanism of choleretics involves activating hepatic transport mechanisms in hepatocytes, promoting the secretion of bile components into canaliculi through enhanced vesicular exocytosis and upregulation of anion exchangers like AE2, which facilitates bicarbonate-rich bile formation.^[44] Hormonal signals, such as secretin, contribute by binding to receptors on cholangiocytes to increase cyclic AMP levels, thereby boosting ductular bicarbonate secretion and supporting overall bile production.00111-2/fulltext) Prominent examples include ursodeoxycholic acid (UDCA), a hydrophilic bile acid that serves as a primary choleretic by altering the bile acid pool toward less toxic forms and stimulating hepatobiliary secretion to improve bile flow in cholestatic conditions.^[44] Herbal agents like boldo (Peumus boldus) also exhibit choleretic effects, with leaf extracts shown in animal studies to enhance bile secretion and protect against hepatic damage through antioxidant activity.^[45] Physiologically, choleretics are particularly beneficial in cholestasis scenarios where bile production by hepatocytes is impaired, such as in primary biliary cholangitis, as they restore secretory function and reduce hepatocyte toxicity without exacerbating flow limitations.^[44]

Distinction from Cholagogues

Cholagogues primarily act by stimulating the contraction of the gallbladder, thereby promoting the release and flow of stored bile into the duodenum, which represents a post-hepatic mechanism focused on evacuation rather than production.^[20] In contrast, choleretics enhance the synthesis and secretion of bile directly by hepatocytes in the liver, addressing pre-storage or hepatic production deficits.^[46] This distinction underscores cholagogues' role in facilitating bile expulsion from the gallbladder, while choleretics target upstream bile formation to increase overall volume.^[20] Despite these differences, significant overlaps exist, as many substances exhibit both cholagogue and choleretic properties, providing dual support for biliary function. For instance, dandelion (Taraxacum officinale) demonstrates both activities, stimulating hepatic bile production while also promoting gallbladder emptying, which can enhance comprehensive bile dynamics in therapeutic contexts.^[47] Such agents are often employed in dual therapy to address multifaceted biliary disorders, combining increased synthesis with improved release for optimal flow.^[46] Clinically, cholagogues are particularly indicated for conditions involving bile stasis or gallbladder dyskinesia, where impaired motility leads to inadequate emptying and potential stone formation.^[1] Choleretics, however, are preferred for hypoproduction or cholestatic states, such as intrahepatic cholestasis, where enhancing liver bile output alleviates accumulation and supports detoxification.^[46] This targeted application allows for precise management, with choleretics like ursodeoxycholic acid serving as first-line agents in cholestasis to stimulate bile flow without exacerbating gallbladder issues.^[46] The terminology of cholagogues and choleretics has evolved from ancient humoral medicine, where "chole" (Greek for bile) reflected one of the four bodily humors, to modern pharmacological precision distinguishing mechanisms of action.^[48] Contemporary classifications, such as those in DrugBank, categorize them based on these specific effects, moving beyond historical purging concepts to evidence-based hepatic and post-hepatic roles.^[20]

References

[1]
Cholagogue - an overview | ScienceDirect Topics
Cholagogue is defined as an agent that stimulates the flow of bile. AI generated definition based on: Immunology and Allergy Clinics of North America, 2002.
[2]
Cholagogues and Choleretics | DrugBank Online
**Definition:**
[3]
https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/750465/0/cholagogue
[4]
CHOLAGOGUE definition in American English - Collins Dictionary
A drug or other substance that promotes the flow of bile from the gall bladder into the duodenum.... Click for pronunciations, examples sentences, video.
[5]
Bile: What It Is, Where It's Made & What It Does - Cleveland Clinic
May 13, 2024 · Bile is a yellowish-green digestive fluid produced by your liver and stored by your gallbladder. It helps your body break down fats in the foods you eat.
[6]
https://www.earlychristianwritings.com/text/galen.html
[7]
Physiology, Bile Secretion - StatPearls - NCBI Bookshelf
Lipid Absorption and Digestion Through emulsification, bile acids break down large lipid droplets into smaller ones, increasing the surface area for digestive ...
[8]
[PDF] Mechanisms of Action of Herbal Cholagogues - Longdom Publishing
Jun 16, 2012 · They are denoted as cholagogues (promoting the flow of bile from the liver and gall bladder into the intestines) and choleretics (increasing ...<|control11|><|separator|>
[9]
(PDF) Mechanisms of Action of Herbal Cholagogues - ResearchGate
Aug 9, 2025 · Herbal cholagogues target different components of the complex bile production and secretion system, and exert their action via diverse routes.
[10]
Cholagogue - an overview | ScienceDirect Topics
In a recently published review of retrospective observational case reports of ocular side effects ... mechanism of action and predict their efficacy. 2.2 ...
[11]
The Legacy of Humoral Medicine - AMA Journal of Ethics
Jul 1, 2002 · Humoral medicine believed illness was caused by imbalances in four bodily fluids (blood, phlegm, yellow bile, and black bile) and their ...Missing: cholagogue | Show results with:cholagogue<|control11|><|separator|>
[12]
Found Vintage: Osgood's India Cholagogue
Aug 7, 2020 · Osgood's India Cholagogue is a patent medicine, a cholagogue that promotes bile flow, introduced by Dr. Charles Osgood in 1830.
[13]
Bile Acids—A Peek Into Their History and Signaling - PMC
The study of bile acids began with Strecker isolating the primary bile acid, cholic acid (CA), in 1848 through combustion analysis, marking the discovery of the ...
[14]
Cholecystokinin—From Local Gut Hormone to Ubiquitous Messenger
Apr 13, 2017 · Cholecystokinin (CCK) was discovered in 1928 in jejunal extracts as a gallbladder contraction factor. It was later shown to be member of a ...
[15]
Synthetic analogs of cholecystokinin terminal tetrapeptide that ...
Two synthetic analogs of CCK-4, Glp-Met-Asp-Phe-NH2 (I) and Pro-Met-Asp-Phe-NH2 (II) reported earlier to stimulate insulin release from the isolated rat ...
[16]
Effect of florantyrone on rate of secretion of hepatic bile and on its ...
Effect of florantyrone on rate of secretion of hepatic bile and on its chemical and physical properties. Gastroenterology. 1959 Dec:37:735-40.Missing: development 1950s dyskinesia
[17]
Silybin, a Major Bioactive Component of Milk Thistle (Silybum ... - NIH
Nov 10, 2017 · Thanks to its healthful properties, silymarin—an extract of milk thistle fruits—was classified by the WHO in the 1970s as an official medicine ...Missing: cholagogue | Show results with:cholagogue
[18]
Effect of silymarin on biliary bile salt secretion in the rat | Request PDF
Aug 7, 2025 · These results suggest that silymarin increases the biliary excretion and the endogenous pool of bile salts by stimulating the synthesis, among ...
[19]
Silymarin as a new hepatoprotective agent in experimental cholestasis
This review addresses in detail a number of recent studies showing a novel feature of silymarin as a hepatoprotective drug, namely: its anticholestatic ...
[20]
Phase 2 Clinical Trials in Primary Sclerosing Cholangitis - PubMed
Phase 2 Clinical Trials in Primary Sclerosing Cholangitis: Making the Most of Every Opportunity? ... J Hepatol. 2025 Nov 4:S0168-8278(25)02605-4.
[21]
Cholagogues and Choleretics | DrugBank Online
Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). Drugs ...Missing: definition | Show results with:definition
[22]
Florantyrone: Uses, Interactions, Mechanism of Action - DrugBank
Jun 9, 2014 · Florantyrone is used in the treatment of biliary dyskinesia. ... Mechanism of action: Not Available; Absorption. Not Available. Volume of ...
[23]
Ursodeoxycholic acid: Uses, Interactions, Mechanism of Action
UDCA was first approved by the FDA in 1987 for dissolution of gallstones and for primary biliary cirrhosis in 1996. UDCA works by replacing the ...Missing: cholagogue | Show results with:cholagogue
[24]
https://pubmed.ncbi.nlm.nih.gov/40050567/
[25]
The effect of ursodeoxycholic acid in dissolving gallstones formed ...
Mar 7, 2025 · Results: Gallstones dissolved in 60% of patients who received UDCA treatment, and symptoms such as dyspepsia decreased. A stone diameter of less ...
[26]
Chenodeoxycholic acid: Uses, Interactions, Mechanism of Action
Chenodeoxycholic acid is a bile acid used for the treatment of primary biliary cirrhosis. Brand Names. Chenodal, Chenodeoxycholic Acid Leadiant, Ctexli. Generic ...Identification · Pharmacology · Products · References
[27]
Ursodeoxycholic acid vs. chenodeoxycholic acid as ... - PubMed
UDCA was equally effective at high and low doses, both on small and large stones. CDCA was significantly more effective at high doses and on small stones.
[28]
Chenodeoxycholic acid: Used Therapeutically to dissolve ...
Feb 7, 2025 · When given for 2 years or more, chenodeoxycholic acid can dissolve cholesterol gallstones in 15% to 30% of patients. Chenodeoxycholic acid is ...
[29]
Correlation Between Gallbladder Size and Release of ... - PMC
This study provides direct evidence that the mechanism of magnesium sulfate-stimulated gallbladder contraction occurs through the release of CCK.Missing: cholagogue | Show results with:cholagogue
[30]
Cholagogue-induced gallbladder emptying in the diagnosis of ...
In 24 icteric dogs, gallbladder contraction was evoked by different cholagogues: the maximum reduction in gallbladder volume (%) for the three non-obstructive ...
[31]
Traditional herbal medicine therapy of gallbladder ascariasis: a case ...
Jan 30, 2021 · Magnesium sulfate combined Uyghur herbal preparations have resolved GA within 4 days, as analyzed by USG, serum and urine tests. Further follow ...Missing: stimulation | Show results with:stimulation
[32]
Artichoke leaf extract reduces mild dyspepsia in an open study
A recent post-marketing study indicated that high doses of standardised artichoke leaf extract (ALE) may reduce symptoms of dyspepsia.Missing: evidence | Show results with:evidence
[33]
Efficacy of artichoke leaf extract in the treatment of patients with ...
The ALE preparation tested was significantly better than the placebo in alleviating symptoms and improving the disease-specific quality of life in patients ...Missing: meta- | Show results with:meta-
[34]
Herbal medicines in functional dyspepsia—Untapped opportunities ...
Nov 30, 2020 · Another meta-analysis focusing on FD showed that RKT compared with prokinetic drugs increased dyspeptic symptom improvement. No adverse reaction ...
[35]
Cholagogue and choleretic - Herbal Reality
Cholagogues have an alterative and laxative effect. Cholagogues are contra-indicated if there is acute liver failure, obstructive jaundice, painful gallstones ...
[36]
Cholagogue - Healthy.net
Dec 6, 2000 · These herbs have a much deeper value than 'simply' the release of bile, they help ensure a strong and healthy liver and so enliven the whole being.
[37]
https://www.drugs.com/mtm/barberry.html
[38]
Barberry Uses, Side Effects & Warnings - Drugs.com
Feb 21, 2025 · Do not use barberry if you are pregnant. Barberry may cause brain damage in a newborn if the mother takes this product during pregnancy. Use ...
[39]
Health Benefits of Barberries
Pregnancy: Pregnant people should not use barberry, as it may stimulate uterine contractions and cause miscarriage. 4. Breastfeeding: The safety of barberry in ...Uses of Barberry · Side Effects · Precautions · Interactions
[40]
Turmeric and warfarin Interactions Checker - Drugs.com
A Moderate Drug Interaction exists between turmeric and warfarin. View detailed information regarding this drug interaction.
[41]
Beware turmeric/curcumin containing products can ... - Medsafe
Apr 30, 2018 · Concurrent use of turmeric/curcumin containing natural health products with these medicines may result in prolonged bleeding times and should be avoided.
[42]
A guide for herb-drug interactions | Safety - Herbal Reality
Feb 14, 2024 · Cholagogue and choleretic · Circulatory ... WHO (2004) WHO Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems.
[43]
[PDF] Chelidonium majus: Relevant safety aspects of a hepatotoxic plant ...
May 4, 2022 · In 2011, the European Medicine Agency (EMA) has reported that a safe oral daily dose limit of C. majus should not exceed 2.5 mg in alkaloids ( ...
[44]
Choleretic - an overview | ScienceDirect Topics
Choleretic refers to the stimulation of bile production by hepatocytes, which enhances bile flow and increases total bile acid concentration in the body. AI ...
[45]
Ursodeoxycholic Acid - StatPearls - NCBI Bookshelf
Feb 12, 2023 · Ursodeoxycholic acid is a medication used to manage and treat cholestatic liver disease. This activity reviews the indications, mechanism of action, and ...
[46]
Boldo Uses, Benefits & Dosage - Drugs.com
The plant is used as a laxative, choleretic (a stimulant of bile secretion), and diuretic, as well as in the treatment of digestive disorders and hepatic ...
[47]
Choleretic - an overview | ScienceDirect Topics
Although choleretics are useful in the treatment of gallstones and other disorders of the digestive tract, they are contraindicated in cases where the flow ...
[48]
Taraxacum—A review on its phytochemical and pharmacological ...
Oct 11, 2006 · Throughout the ages, several health-promoting benefits, including diuretic, laxative, cholagogue, anti-rheumatic, anti-inflammatory, choleretic, ...
[49]
choleretic - Wiktionary, the free dictionary
From German cholereticum, from modern Latin choleresis (“bile secretion from the liver”) (modelled on diuretic). Adjective. choleretic (comparative more ...